highly significantp < 0.01
Comparison between parallel arm I with parallel arm II from baseline to 3 months showed mild significance ( p < 0.05) however as trial progressed highly significant ( p < 0.01) difference was observed at 12th month (end of trial) (Fig. 2 ).